FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to pharmaceutically active compounds. Disclosed is a compound of formula I, where R1, R2, n, X, Q, L, m, R3 and p are as defined by the claims. Also disclosed are embodiments of a method of producing said compound, embodiments of using said compound for producing a drug for treating diseases characterized by disturbed signalling pathways of neurotrophins and/or other trophic factors, and for the treatment of a disease characterized by disturbed signalling pathways of neurotrophins and/or other trophic factors, as well as a pharmaceutical composition containing a compound of formula I, and a method of treating said diseases using the disclosed compound.
EFFECT: disclosed compound is a positive modulator of receptors TRK A, TRK B and TRK C and receptor tyrosine kinases IGF1R and FGF1R.
21 cl, 1 dwg, 1 tbl, 78 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRIMERIC QUATERNARY PYRIDINIUM SALTS WITH BIOCIDAL ACTION | 2021 |
|
RU2773080C1 |
| DERIVATIVES OF 7-OXO-1,6-DIAZABICYCLO[3.2.1]OCT-3-ENE, USEFUL FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2645678C2 |
| OXOPICOLINAMIDE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2017 |
|
RU2742771C2 |
| N-PIPERIDIN-3-YL-BENZAMIDE DERIVATIVES FOR CARDIOVASCULAR DISEASES TREATMENT | 2014 |
|
RU2618628C1 |
| NOVEL COMPOUNDS | 2015 |
|
RU2691389C2 |
| INFLUENZA VIRUS REPLICATION INHIBITORS, METHODS OF APPLICATION AND USING | 2016 |
|
RU2737190C2 |
| NEW PYRROLO[3,2-d]PYRIMIDIN-4-ONE DERIVATIVES AND USING THEM IN THERAPY | 2005 |
|
RU2577858C2 |
| DERIVATIVES OF THIOXANTHINE AS MYELOPEROXIDASE INHIBITORS | 2003 |
|
RU2323219C2 |
| PYRIDYL KETONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATION THEREOF | 2014 |
|
RU2667892C2 |
| TRIAZOLPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATMENT OF CANCER | 2019 |
|
RU2793249C2 |
